MEC Basic Full List ViewBy pinki@katapult.biz / February 16, 2025 MEC Basic Speciality — Amyotrophic Lateral Sclerosis (ALS) Biomarkers Biosimilars Bladder Blood Bone Brain Breast Cancer Central Nervous System (CNS) Clinical Trials Colon Colorectal Diversity, Equity & Inclusion Featured Content Gastrointestinal Genitourinary Genomic Geriatric Gynecology Head and Neck Hematologic Hematologic Maglinencies Hematology Immunotherapy Interventional Radiology Kidney Leukemia Liquid Biopsy Liver Lung Lymphoma Malignant Malignencies Melanoma Myelodysplastic Syndrome Myeloma Neuroendocrine Novel Oral & Maxillofacial Surgery Oral Cancer Ovarian Pancreas Pancreatic Pharmacological Prostate Radiation Radiology Renal Sarcoma Skin Solid Tumor Supportive & Palliative Care Survivorship Telemedicine Thoracic Thrombosis Thymic Thyroid Urothelial Author / Speaker Title Type of Media — Video Document Audio Events — 2024 California Cancer Consortium Conference (CCC) 2024 MCM 2024 MCM 2024 MLS Cleveland 2024 MLS Nashville 2024 MLS New Orleans 2024 MLS Seattle 2024 New Orleans Summer Cancer Meeting (NOSCM) 2024 PRIMO 2024 SPS Puerto Rico 2024 SPS Seattle 2024 SPECTRUM 2024 Sylvester APP Oncology Symposium 2024 WCS 2024 MaTOS Lungs 2025 PRIMO Search Entries: « 1 … 26 27 28 29 30 … 74 » New Biomarkers in Breast Cancer Tanya Gupta, MD View PDF Hormone Therapy in Breast Cancer: New Directions Mili Arora, MD View PDF ADCs in Cancer Mille Das, MD View PDF PIK3CA/AKT/mTOR Jacob Thomas, MD View PDF DDR and DNA-Repair Pathways and Targets Mamta Parikh, MD, MS View PDF BTK inhibitors, BCL-2 Inhibitors and Novel Targets in Hematology Tycel Phillips, MD View PDF Contemporary Management of Urothelial Cancer Abhishek Tripathi, MD View PDF Renal Cell Cancer: Recent Advances Suchi Gulati, MD, MS, FACP View PDF Castration Resistant Prostate Cancer: What is the optimal treatment? Sandy Srinivas, MD View PDF State of the Art: Hormone-sensitive Prostate Cancer Sarmad Sadeghi, MD, PhD View PDF Lymphoma: State of the Art Alex Herrera, MD View PDF AML and MDS: Beyond 7+3 Kevin Kelly, MD, PhD View PDF The Future of Developmental Therapeutics in Oncology Patricia Mucci LoRusso, DO, PhD View PDF Updates in Treatment of Early Stage and Locally Advanced NSCLC Jorge Nieva, MD View PDF Advances in Small Cell Lung Cancer and Mesothelioma/Thymic Malignancies Jyoti Malhotra, MD, MPH View PDF Updates in Targeted Therapy for NSCLC Jonathan W. Riess, MD, MS View PDF Updates in Immunotherapy for Lung Cancer Mykola Onyshchenko, MD, PhD View PDF Advances in Esophageal and Gastric Cancer Syma Iqbal, MD View PDF Colorectal Cancer: State of the Art Heinz-Josef Lenz, MD, FACP View PDF Pancreatic and Hepatobiliary Cancer: Emerging Strategies Edward Kim, MD, PhD View PDF Management of Immune Related Adverse Events Mary I. Carroll, DNP, FNP-C, OCN View PDF Advances in Car-T Cells Development for Cancer Therapy Mohamed Abou-el-Enein, MD, PhD, MSPH View PDF Advances in Non-PD(L)1 Immunotherapies Miguel Villalona-Calero View PDF Convergence of Liquid Biopsy and Precision Oncology in the Management of NSCLC David Gandara, MD & Jonathan W. Riess, MD, MS View PDF Translating Pre-Clinical Studies to NCI-CTEP Clinical Trials Steven D. Gore, MD View PDF
